Patients with detectable PSA post-prostatectomy should receive more aggressive radiation therapy
2/10/2015
Ten-year post-treatment analysis of German ARO 96-02Prostate cancer patients with detectable prostate specific antigen (PSA) following radical prostatectomy should receive earlier, more...
CNIO scientists link aggressiveness of chronic lymphocytic leukaemia to genetic variability
2/10/2015
The genetic variability of a tumour could be a predictor for its aggressiveness: the greater the variability in gene expression, the more aggressive the tumour is likely to be.
Taking immunosuppressives, anti-cancer drugs may reactivate hepatitis B
2/10/2015
Individuals previously infected with the hepatitis B virus (HBV) who receive chemotherapy or immunosuppressive treatment may be at risk of reactivating the disease according to a summary of report...
New approach to colorectal surgical care results in quicker recovery times and lower costs
2/10/2015
New study utilizing the ACS NSQIP risk calculator demonstrates how a new protocol for colorectal surgical care improves patient outcomes and increases patient satisfactionA new multidisciplinary...
New study sheds light on cancer stem cell regulation
2/10/2015
Researchers identify signaling molecules in intestinal stem cells that can lead to tumors if left unregulated. The findings suggest a new approach to targeting intestinal cancers.
Cell signaling pathway goes awry in common pediatric brain tumor
2/10/2015
A new study by Johns Hopkins researchers links a well-known cell communication pathway called Notch to one of the most common -- but overall still rare -- brain tumors found in children.
Salicylates, a class of NSAIDs, stop vestibular schwannomas growth
2/10/2015
Researchers from Massachusetts Eye and Ear and the Harvard Medical School/ Massachusetts Institute of Technology's Program in Speech and Hearing Bioscience and Technology have demonstrated that...
An 'ambulance' for the brain
2/10/2015
Chemists at IRB Barcelona patent and present a shuttle capable of transporting molecules into the brain; this achievement could facilitate the treatment of diseases with no therapy available.
Analysis: High-cost blood cancer drugs deliver high value
2/10/2015
Amid the growing debate about the high price of powerful new drugs in the United States, a recent analysis suggests that breakthrough therapies for blood cancers may, in many cases and with some...
Patients with detectable PSA post-prostatectomy should receive more aggressive radiation therapy
2/10/2015
Ten-year post-treatment analysis of German ARO 96-02Prostate cancer patients with detectable prostate specific antigen (PSA) following radical prostatectomy should receive earlier, more...
